Tata Nifty MidSmall Healthcare Index Fund Regular Growth is a mutual fund scheme from Tata Asset Management Pvt Ltd. The fund was launched on 26 April 2024 and is managed by Rakesh Prajapati and Nitin Sharma. As of 15 October 2026, the fund has an AUM of ₹220.69 Cr and its latest NAV is ₹14.32. The fund has a Very High Risk risk rating.
The fund allows minimum SIP of ₹100 and lumpsum investment starting from ₹5,000.
The fund primarily invests in Healthcare and Basic Materials and its top holdings include Laurus Labs Ltd, Lupin Ltd, Aurobindo Pharma Ltd, Fortis Healthcare Ltd, and Glenmark Pharmaceuticals Ltd. The fund has delivered 11.6% returns over the last 1 year and 15.7% annualised returns since inception.
Tata Nifty MidSmall Healthcare Index Fund Regular Growth may be suitable for investors looking for long-term wealth creation and who are comfortable with Very High Risk risk.






